Oral ulcers were improved; however, following addition of the PDE4 inhibitor, apremilast, to her treatment regimen, suggesting that signalling pathways other than those directly mediated by the NLRP3 inflammasome were dysregulated. The gene discussed is NLRP3; the disease is Oral ulcer.